The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression

Hengshu Chen, Xia Huang, Chang Zeng, Dongren Sun, Fan Liu, Jingyuan Zhang, Qiao Liao, Shihang Luo, Weiye Xu, Yeqing Xiao, Danfeng Zeng, Mingyu Song, Fafa TianFrontiers in Immunology 2023 · DOI

Abstract: Our findings provided evidence that IDO1 gene polymorphisms and protein levels were involved in the development of early-onset PSD and TNF-α polymorphism was associated with IDO1 levels, supporting that IDO1 which underlie strongly regulation by cytokines may be a specific pathway for the involvement of immune-inflammatory mechanism in the pathophysiology of PSD.

Introduction

Post-stroke depression (PSD) affects approximately one-third of stroke survivors, significantly hindering functional recovery and increasing mortality. While the "immune-inflammatory response" has long been suspected as a driver, the exact biological bridge between brain injury and depressive symptoms remains a subject of intense research.

A leading theory involves the tryptophan-kynurenine pathway. Tryptophan is an essential amino acid used to synthesize serotonin, the "feel-good" neurotransmitter. During inflammation, the enzyme indoleamine 2,3-dioxygenase 1 (IDO1) can "hijack" tryptophan, diverting it to produce kynurenine metabolites, some of which are neurotoxic. This study investigates whether genetic predispositions in the IDO1 pathway and serum protein levels can predict early-onset depression following a stroke.

Methods

Researchers conducted a prospective study of 186 acute stroke patients at Xiangya Hospital, China. Depressive symptoms were evaluated 14 days post-stroke using DSM-5 criteria. The team utilized SNPscan™ technology to analyze 15 single nucleotide polymorphisms (SNPs) in the IDO1 and IDO2 genes, as well as genes for inflammatory inducers like IFN-γ and TNF-α. Serum IDO1 protein levels were measured using a double-antibody sandwich ELISA.

Table 1: Baseline characteristics of the study cohort, comparing patients with and without post-stroke depression (PSD).

Key Results

Of the 186 patients, 31.72% (59 individuals) were diagnosed with early-onset PSD. Baseline analysis (Table 1) showed significant differences in gender (p=0.043) and years of education (p=0.018) between the PSD and non-PSD groups.

Genetic and Protein Risk Factors

The study identified the rs9657182 polymorphism in the IDO1 gene as a major risk factor. Patients with the T/T genotype were three times more likely to develop early-onset PSD (Adjusted OR = 3.008, p = 0.024). Additionally, higher serum IDO1 levels were independently linked to PSD risk (Adjusted OR = 1.071, p = 0.044).

The Synergy of Genetics and Inflammation

Interestingly, higher serum IDO1 levels were only significantly linked to depression in patients who carried the rs9657182 T allele. This suggests that genetic susceptibility and actual protein expression work in tandem to drive the disease. Furthermore, a specific variant in the TNF-α gene (rs361525) was associated with higher serum IDO1 levels, suggesting a hierarchical mechanism where stroke-induced inflammation triggers IDO1, which then triggers depression.

Figure 1: Comparison of serum IDO1 concentrations by genotype and PSD status. Significant differences (indicated by *) were observed in patients carrying the T allele.

Discussion and Future Work

These findings support the hypothesis that IDO1 acts as a metabolic "sink," depleting serotonin and creating a "perfect storm" for depression following a stroke. The association with TNF-α suggests that IDO1 is a specific pathway for immune-inflammatory involvement in PSD pathophysiology.

However, the study is limited by its focus on early-onset PSD (2 weeks post-stroke); the mechanisms for late-onset PSD may differ. Additionally, while serum levels reflect systemic inflammation, they may not perfectly mirror enzyme activity within the brain's microenvironment. Future multi-center trials are needed to confirm these genetic associations across more diverse populations.

Summary updated

Abstract

Our findings provided evidence that IDO1 gene polymorphisms and protein levels were involved in the development of early-onset PSD and TNF-α polymorphism was associated with IDO1 levels, supporting that IDO1 which underlie strongly regulation by cytokines may be a specific pathway for the involvement of immune-inflammatory mechanism in the pathophysiology of PSD.
BibTeX
@inproceedings{chen2023role,
  author = {Hengshu Chen and Xia Huang and Chang Zeng and Dongren Sun and Fan Liu and Jingyuan Zhang and Qiao Liao and Shihang Luo and Weiye Xu and Yeqing Xiao and Danfeng Zeng and Mingyu Song and Fafa Tian},
  title = {{The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression}},
  booktitle = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2023.1125634},
}
Figure